Inhibition of DNA Polymerases by Uracil-Dna Glycosylase-Cleavable Oligonucleotide Ligands
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- CEPHEID, Sunnyvale, California has been assigned a patent (No. US 12168786 B2, initially filed March 7, 2022) developed by Igor V. Kutyavin, Woodinville, Washington, and Sergey G. Lokhov, Bothell, Washington, for "Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands." . . .